Patents Assigned to Wellington Laboratories Inc.
  • GLYCYRRHETINIC ACID DERIVATIVES
    Publication number: 20130210926
    Abstract: The present invention relates to novel derivatives of glycyrrhetinic acid, compositions comprising said derivatives and their use in the treatment of conditions or diseases that benefits from an upregulation of PPAR? and/or a downregulation of the expression or activity of one or more specificity (Sp) proteins, such as cancer, diabetes and Huntington's disease.
    Type: Application
    Filed: February 5, 2013
    Publication date: August 15, 2013
    Applicants: The Texas A&M University System, Wellington Laboratories Inc.
    Inventors: Stephen H. Safe, Sudhakar Chintharlapalli, Alan McAlees, Robert McCrindle
  • Glycyrrhetinic acid derivatives
    Patent number: 8389573
    Abstract: The present invention relates to novel derivatives of glycyrrhetinic acid, compositions comprising said derivatives and their use in the treatment of conditions or diseases that benefit from an upregulation of PPAR&ggr; and/or a downregulation of the expression or activity of one or more specificity (Sp) proteins, such as cancer, diabetes and Huntington's disease.
    Type: Grant
    Filed: June 27, 2007
    Date of Patent: March 5, 2013
    Assignees: Wellington Laboratories Inc., The Texas A&M University System
    Inventors: Stephen H. Safe, Sudhakar Chintharlapalli, Alan McAlees, Robert McCrindle